Fredun Pharmaceuticals Ltd
In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended ....
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 05 Aug 2026, 11:38 AM IST · BSE ID: d6ddf948-1ca9-4865-b124-c4a6a6ac7204
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board reviewed and approved its financial performance for the first quarter of the fiscal year.
🤖 AI Summary
- Fredun Pharmaceuticals Board approved Un-Audited Financial Results for the quarter ended 30th June, 2026.
- Results were adopted in compliance with Regulations 30 and 33 of SEBI (LODR) Regulations, 2015.
- A Limited Review Report from M/s. R.H. Nisar & Co, Statutory Auditor, accompanied the results.
- The trading window for company insiders closed on July 01, 2026, and will reopen 48 hours after this declaration.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are informed of the completion of the board's review and approval process for the quarter's financial results.
🔍
Management Signal
Management confirmed adherence to regulatory disclosure timelines by approving and filing the un-audited quarterly results.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Wait for detailed financial results to be made publicly available.
Review the Limited Review Report from the statutory auditor.
Monitor future announcements for operational or strategic updates.
LOW RISK
This filing is a routine disclosure of board meeting outcomes, confirming results approval without specific financial data.
💡 Investor Takeaway
The Board of Fredun Pharmaceuticals Ltd approved the Un-Audited Financial Results for the quarter ended 30th June, 2026, in a meeting held on August 05, 2026. Specific financial figures for the period were not disclosed within this filing.
❓ Frequently Asked Questions
What was the key outcome of Fredun Pharmaceuticals' Board Meeting on August 05, 2026?
The Board of Directors considered, adopted, and approved the Un-Audited Financial Results for the quarter ended 30th June, 2026.
Which regulations did Fredun Pharmaceuticals comply with for this filing?
Fredun Pharmaceuticals complied with Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Who reviewed the financial results for Fredun Pharmaceuticals for Q1 FY27?
The Un-Audited Financial Results for the quarter ended 30th June, 2026, included a Limited Review Report issued by M/s. R.H. Nisar & Co, Statutory Auditor.
When did the trading window close for insiders at Fredun Pharmaceuticals?
The trading window for insiders at Fredun Pharmaceuticals closed on July 01, 2026, and will reopen 48 hours after the declaration of the board meeting outcome.
Questions based on this BSE filing only. For information purposes.